Niraj Shrestha,Pallavi Chaturvedi,Xiaoyun Zhu,Michael J. Dee,Varghese George,Christopher Janney,Jack O. Egan,Bai Liu,Mark Foster,Lynne Marsala,Pamela Wong,Celia C. Cubitt,Jennifer A. Foltz,Jennifer Tran,Timothy Schappe,Karin Hsiao,Gilles M. Leclerc,Lijing You,Christian Echeverri,Catherine Spanoudis,Ana Carvalho,Leah Kanakaraj,Crystal Gilkes,Nicole Encalada,Lin Kong,Meng Wang,Byron Fang,Zheng Wang,Jin‐an Jiao,Gabriela J. Muniz,Emily K. Jeng,Nicole Valdivieso,Liying Li,Richard Deth,Melissa M. Berrien‐Elliott,Todd A. Fehniger,Peter R. Rhode,Hing C. Wong

Abstract:Bifunctional immunotherapeutic HCW9218 functions as a novel SNC‐reducing and senomorphic agent in mice. Subcutaneous administration of HCW9218 activates NK, innate lymphoid group‐1, and CD8+ T cells, and neutralizes TGF‐ß to reduce senescent cells (SNC‐reducing) and SASP (senomorphic) leading to lower chronic inflammation and restored tissue homeostasis. Accumulation of senescent cells (SNCs) with a senescence‐associated secretory phenotype (SASP) has been implicated as a major source of chronic sterile inflammation leading to many age‐related pathologies. Herein, we provide evidence that a bifunctional immunotherapeutic, HCW9218, with capabilities of neutralizing TGF‐β and stimulating immune cells, can be safely administered systemically to reduce SNCs and alleviate SASP in mice. In the diabetic db/db mouse model, subcutaneous administration of HCW9218 reduced senescent islet β cells and SASP resulting in improved glucose tolerance, insulin resistance, and aging index. In naturally aged mice, subcutaneous administration of HCW9218 durably reduced the level of SNCs and SASP, leading to lower expression of pro‐inflammatory genes in peripheral organs. HCW9218 treatment also reverted the pattern of key regulatory circadian gene expression in aged mice to levels observed in young mice and impacted genes associated with metabolism and fibrosis in the liver. Single‐nucleus RNA Sequencing analysis further revealed that HCW9218 treatment differentially changed the transcriptomic landscape of hepatocyte subtypes involving metabolic, signaling, cell‐cycle, and senescence‐associated pathways in naturally aged mice. Long‐term survival studies also showed that HCW9218 treatment improved physical performance without compromising the health span of naturally aged mice. Thus, HCW9218 represents a novel immunotherapeutic approach and a clinically promising new class of senotherapeutic agents targeting cellular senescence‐associated diseases.

Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice

Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics

NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates

Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice

NAD+ supplementation prevents STING‐induced senescence in CD8+ T cells by improving mitochondrial homeostasis

Senolytics improve physical function and increase lifespan in old age

Targeting senescent cells with NKG2D-CAR T cells

Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice

Senolytic Therapy Enabled by Senescent Cell‐Sensitive Biomimetic Melanin Nano‐senolytics

Senescent Cell-Secreted Netrin-1 Modulates Aging-Related Disorders by Recruiting Sympathetic Fibers

Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells

The combination of nicotinamide mononucleotide and lycopene prevents cognitive impairment and attenuates oxidative damage in D-galactose induced aging models via Keap1-Nrf2 signaling

Proteomic analysis of anti-aging effects of Dendrobium nobile Lindl. alkaloids in aging-accelerated SAMP8 mice

Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria

A Chimeric Peptide Promotes Immune Surveillance of Senescent Cells in Injury, Fibrosis, Tumorigenesis and Aging

Advances in Nanotherapy for Targeting Senescent Cells

Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial

NAD+ Repletion Improves Mitochondrial and Stem Cell Function and Enhances Life Span in Mice

Nicotinamide Mononucleotide Ameliorates Senescence in Alveolar Epithelial Cells

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis